Pictet Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,075
Closed -$201K 2136
2025
Q3
$201K Buy
+7,075
New +$192K ﹤0.01% 1876
2025
Q2
Sell
-7,075
Closed -$219K 2062
2025
Q1
$219K Hold
7,075
﹤0.01% 1758
2024
Q4
$223K Buy
7,075
+1,273
+22% +$60.5K ﹤0.01% 1798
2024
Q3
$336K Buy
5,802
+615
+12% +$30.2K ﹤0.01% 1546
2024
Q2
$210K Hold
5,187
﹤0.01% 1729
2024
Q1
$218K Buy
+5,187
New +$202K ﹤0.01% 1733

Other funds holding ASTH

Pictet Asset Management's ASTH Position: Q4 2025 in Review

Pictet Asset Management sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 7,075 shares — an estimated $201K sold.

Pictet Asset Management first reported a position in ASTH in Q1 2024 and held it in 6 quarters. The position peaked at $336K in Q3 2024. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Pictet Asset Management reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Pictet Asset Management sold 7,075 Astrana Health shares in Q4 2025, an estimated $201K.
  • Pictet Asset Management first reported a position in Astrana Health in Q1 2024 and held it in 6 quarters.
  • Pictet Asset Management's Astrana Health position peaked at $336K in Q3 2024.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Pictet Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.